Related Experiment Videos
Heart rate variability in human immunodeficiency virus-positive individuals
Chander Mohan Mittal1, Naveet Wig, Sundeep Mishra
1Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
International Journal of Cardiology
|March 5, 2004
Summary
Heart rate variability (HRV) is reduced in individuals with human immunodeficiency virus (HIV) even before AIDS develops. This early reduction in HRV may signal future autonomic nervous system imbalances.
Area of Science:
- Cardiology
- Immunology
- Autonomic Neuroscience
Background:
- Heart rate variability (HRV) reflects cardiac autonomic tone.
- Previous studies indicated depressed HRV in patients with Acquired Immunodeficiency Syndrome (AIDS).
- The current study investigated HRV in human immunodeficiency virus (HIV)-positive individuals without AIDS.
Purpose of the Study:
- To determine if HRV is depressed in HIV-positive individuals without AIDS.
- To assess HRV as a potential early marker of autonomic dysfunction in HIV infection.
Main Methods:
- Prospective study involving spectral analysis of short-term electrocardiography (ECG) monitoring.
- 21 HIV-positive individuals (without AIDS or clinical autonomic dysfunction) and 18 healthy volunteers were studied.
- Echocardiography was performed in HIV-positive individuals to exclude left ventricular systolic dysfunction.
Main Results:
- A significant reduction in total HRV power was observed in HIV-positive individuals compared to controls (p<0.00001).
- All measured components of HRV were found to be reduced in the HIV-positive group.
- Mean CD4+ lymphocyte count was 426+/-166/mm(3) and ejection fraction was 62.4+/-6.4% in HIV patients.
Conclusions:
- HRV is significantly reduced in early-stage HIV infection, even without clinical autonomic dysfunction.
- This reduction in HRV may serve as an early indicator of developing sympatho-vagal imbalance.
- HRV assessment could be a valuable tool for monitoring autonomic health in HIV-positive individuals.